BIOMAT Database Logo BIOMAT Database Logo

Cholesterol-lowering agent in men without CHD. 1996

P Millard, and K H Johnson
Family Practice Residency Program, Eastern Maine Medical Center, Bangor, ME 04401, USA.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000924 Anticholesteremic Agents Substances used to lower plasma CHOLESTEROL levels. Cholesterol Inhibitors,Hypocholesteremic Agents,Anticholesteremic Drugs,Anticholesteremics,Inhibitors, Cholesterol,Agents, Anticholesteremic,Agents, Hypocholesteremic,Drugs, Anticholesteremic
D012606 Scotland The most northerly of the four countries of the United Kingdom, occupying about one-third of the island of Great Britain. The capital is Edinburgh.

Related Publications

P Millard, and K H Johnson
Cholesterol lowering in patients with CHD and metabolic syndrome.
January 2007, Lancet (London, England),
P Millard, and K H Johnson
Cholesterol lowering in patients with CHD and metabolic syndrome.
January 2007, Lancet (London, England),
P Millard, and K H Johnson
Cholesterol lowering in patients with CHD and metabolic syndrome.
January 2007, Lancet (London, England),
P Millard, and K H Johnson
Cholesterol lowering in patients with CHD and metabolic syndrome.
January 2007, Lancet (London, England),
P Millard, and K H Johnson
Lovastatin: cholesterol-lowering agent.
December 1987, American family physician,
P Millard, and K H Johnson
Cholesterol-lowering agent myopathy (CLAM).
July 1991, Neurology,
P Millard, and K H Johnson
Lignin: A cholesterol-lowering agent?
December 1973, Lancet (London, England),
P Millard, and K H Johnson
Lowering risk without lowering cholesterol: implications for national cholesterol policy.
September 1996, Annals of internal medicine,
P Millard, and K H Johnson
Cardiorespiratory fitness, LDL cholesterol, and CHD mortality in men.
November 2012, Medicine and science in sports and exercise,
P Millard, and K H Johnson
Lovastatin: a new cholesterol-lowering agent.
January 1987, Pharmacotherapy,
Copied contents to your clipboard!